Metabolomics Solutions

Our Metabolomics Solutions

Why Metabolomics?

Metabolomics provides a snapshot of all biochemicals present in a sample (organ, tissue, biological fluid, cell, or organism, plant, food, wastewater, crude oil) by identifying, quantifying, and mapping each biomolecule in the system. Mass spectrometry and NMR spectroscopy are the techniques most often used for metabolome identification in the applications such as:

Therapeutics: Supports drug development and disease insights.
Biotech & Pharmacy: Tracks metabolic changes for treatment discovery.
Nutrition: Evaluates dietary impacts on health.
Agriculture: Characterizes plant traits and stress responses.
Environment: Monitors pollution and ecosystem health.
Oil & Gas: Analyzes crude oil metabolites and corrosion processes.

Simpler and Faster Metabolomics

Currently, metabolomics approaches are hampered by complex and time-consuming workflows that are are difficult to implement in real-world scenarios. The existing workflows features high costs for the consumables, required for sample pre-processing (most of which are not optimized for metabolomic platforms) and rely on highly trained metabolomics experts to run the analytical instrumentation and interpret the resulting data. Our platforms provide everything researchers need to conduct reliable metabolomics analyses quickly and easily, without requiring specialized expertise. With the EasyOmics plates and metabolite standard mixes, researchers can conduct high-quality metabolomics analyses faster and more affordably than ever before. Our technology can be utilized in many different applications, including diagnosing bacterial infections, detecting cancer, and discovering new drugs.

Read Less Read More

Precision Diagnostics

Metabolomics for Precision Diagnostics

Metabolomics enables precision diagnostics by detecting disease-specific metabolite signatures through a non-invasive and highly sensitive approach. Bloodstream infection (BSI) is a severe, potentially fatal condition, causing over 2 million cases and 250,000 deaths annually in North America and Europe. Mortality rises by ~8% for every hour antibiotic treatment is delayed, and incorrect early treatment can increase death risk up to ten-fold.Rapid assessment of bacterial antibiotic resistance is essential to improve outcomes. However, conventional culture-based and antibiotic susceptibility testing (AST) methods are costly, labor-intensive, require large sample volumes (10–30 mL), and typically take 3–5 days.

The EasyOmics Plate, designed for research use, integrates sample incubation and analysis in a single workflow and couples with mass spectrometry to enable faster antibiotic susceptibility testing.